TELAVANCIN 30 UG, BBL SENSI-DISC
K-Number: K100722 · 2010-03-29
Advertisement
Device Summary
Frequently Asked Questions
What is the TELAVANCIN 30 UG, BBL SENSI-DISC?
TELAVANCIN 30 UG, BBL SENSI-DISC is a medical device that received FDA 510(k) clearance on 2010-03-29. The listed applicant is Becton, Dickinson and Company. The 510(k) number is K100722.
When did TELAVANCIN 30 UG, BBL SENSI-DISC receive FDA 510(k) clearance?
TELAVANCIN 30 UG, BBL SENSI-DISC received FDA 510(k) clearance on 2010-03-29, under 510(k) number K100722.
Who is the listed applicant for TELAVANCIN 30 UG, BBL SENSI-DISC?
The FDA 510(k) record lists Becton, Dickinson and Company as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for TELAVANCIN 30 UG, BBL SENSI-DISC?
The FDA product code for TELAVANCIN 30 UG, BBL SENSI-DISC is JTN.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Becton, Dickinson and Company as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: JTN)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.
Advertisement